Solid Biosciences (SLDB) Interest Expenses (2017 - 2026)
Solid Biosciences (SLDB) posted Interest Expenses of $5.4 million for Q1 2026, up 23.88% sequentially from $4.4 million in Q4 2025, and up 3779.29% YoY from $140000.0 in Q1 2025.
Solid Biosciences (SLDB) Interest Expenses (2017 - 2026) Analysis & Trends
Solid Biosciences has reported Interest Expenses for 10 years, with the latest figure at $5.4 million in Q1 2026.
- Quarterly Interest Expenses rose 3779.29% year-over-year to $5.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $5.4 million (up 3779.29% YoY) and the FY2025 annual result came in at $190.4 million, up 45.72% from the prior year.
- Interest Expenses grew to $5.4 million in Q1 2026 per SLDB's latest filing, from $4.4 million in the prior quarter.
- Over five years, Interest Expenses peaked at $163.6 million in Q4 2022 and troughed at $51000.0 in Q1 2022.
- A 5-year average of $10.9 million and a median of $140000.0 in 2025 frame the typical range for Interest Expenses.
- The sharpest annual moves came in 2023 and 2026: Interest Expenses sank 97.46% in 2023, then jumped 3779.29% in 2026.
- Over 5 years, Interest Expenses stood at $163.6 million in 2022, then tumbled by 97.46% to $4.2 million in 2023, then declined by 3.92% to $4.0 million in 2024, then advanced by 9.63% to $4.4 million in 2025, then rose by 23.88% to $5.4 million in 2026.
- According to Business Quant data, Interest Expenses over the past three periods registered $5.4 million, $4.4 million, and $1.7 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int Expense (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 439.40 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 52.50 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 2.70 Bn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 39.74 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 335,572.77 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 218.10 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 82.05 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 20.27 Mn |
| 10 | Solid Biosciences | 1.32 Bn | 1.32 Bn | - | 23.12 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 23.12 Mn |
| Jun 30, 2026 | 23.12 Mn |
| Mar 31, 2026 | 5.43 Mn |
| Mar 31, 2026 | 5.43 Mn |
| Dec 31, 2025 | 4.38 Mn |
| Dec 31, 2025 | 4.38 Mn |
| Sep 30, 2025 | 1.66 Mn |
| Sep 30, 2025 | 1.66 Mn |
| Jun 30, 2025 | 467,000.00 |
| Jun 30, 2025 | 467,000.00 |
| Mar 31, 2025 | 140,000.00 |
| Mar 31, 2025 | 140,000.00 |
| Dec 31, 2024 | 4.00 Mn |
| Dec 31, 2024 | 4.00 Mn |
| Sep 30, 2024 | 82,000.00 |
| Sep 30, 2024 | 82,000.00 |
| Jun 30, 2024 | 88,000.00 |
| Jun 30, 2024 | 88,000.00 |
| Mar 31, 2024 | 95,000.00 |
| Mar 31, 2024 | 95,000.00 |